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Abstract
Background: Cervical cancer is currently ranked as the fourth commonly diagnosed cancer in women globally.
A higher incidence has been reported in low- and-middle-income countries, and the disease poses significant
public health challenges. Evidence suggests that this disease is preventable by means of regular screening using
the Papanicolaou (Pap) test. However, limited knowledge exists about disparities in cervical screening participation
among immigrants compared with non-immigrants, in countries with universal cervical screening programmes.
We aimed to examine disparities in cervical screening participation among women of Russian, Somali, and Kurdish,
origin in Finland, comparing them with the general Finnish population (Finns). We controlled for differences in
several socio-demographic and health-related variables as potential confounders.
Methods: We employed data from the Finnish Migrant Health and Well-being Study 2010–2012 and the National
Health 2011 Survey. Data collection involved face-to-face interviews. Data on screening participation in the previous
five years from women aged 29–60 were available from 537 immigrants (257 Russians, 113 Somalis, 167 Kurds) and
from 436 Finns. For statistical analyses, we used multiple logistic regression.
Results: Age-adjusted screening participation rates were as follows: Russians 79% (95% CI 72.9–84.4), Somalis 41%
(95% CI 31.4–50.1), and Kurds 64% (95% CI 57.2–70.8), compared with 94% (95% CI 91.4–95.9) among Finns. After
additionally adjusting for socio-demographic and health-related confounders, all the immigrant groups showed a
significantly lower likelihood of screening participation when compared with Finns. The Odds Ratios were as follows:
Russians 0.32 (95% CI 0.18–0.58), Somalis 0.10 (95% CI 0.04–0.23), and Kurds 0.17 (95% CI 0.09–0.35). However, when
additionally accounting for country of origin-confounder interactions, such differences were attenuated.
Conclusions: Our results indicate disparities in screening participation among these immigrants and a lower likelihood
of screening participation compared with the general Finnish population. To improve equity in cervical cancer
screening participation, appropriate culturally tailored intervention programmes for each immigrant group might
be beneficial.
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Background
Cervical cancer is currently ranked as the fourth com-
monly diagnosed cancer in women globally [1, 2]. A
higher incidence of the disease has been reported in
low- and-middle-income countries (LMICs) [1]. World-
wide, approximately 528,000 new cases of cervical can-
cer and 266,000 deaths resulting from the disease were
reported in 2012. Nearly 90% of that mortality was in
LMICs [1, 3]. Considerable evidence proves that the
Papanicolaou (Pap) test is an effective screening tool for
early detection of “pre-cancerous lesions,” with a follow-
up procedure and a better prognosis [3–5]. Therefore,
cervical screening and follow-up are recommended for
all asymptomatic women [5, 6], irrespective of cultural
background. The incidence of, and mortality resulting
from cervical cancer have substantially declined in most
developed countries [3–5, 7, 8]. However, the use of this
healthcare service in some countries offering universal
cervical screening involves significant racial or ethnic
disparities [9–19]. This reflects that having the right, or
equal access, to healthcare services, such as cervical
screening, does not guarantee equal utilisation of the
service [12, 20].
It is essential to explore disparities in cervical screen-
ing participation among various immigrant groups and
non-immigrants, even when universal screening exits.
Previous studies have revealed a higher risk of cervical
cancer among women who seldom participate in screening
or those not screened, compared with regularly screened
women [21, 22]. Notably, studies have reported a higher
risk of the disease among some immigrant groups com-
pared with non-immigrants in several countries offering a
universal screening programme [4, 11, 12, 16, 23].
Previous international studies have indicated that
some socio-economic and health-related determinants
are associated with non-adherence to screening recom-
mendations. Thus, differences in these determinants
would indicate additional potential disparities, which
may confound disparities observed in cervical screening.
Such determinants include a low educational level, un-
employment, being unmarried, limited language profi-
ciency, lack of knowledge of screening, and previous
unpleasant screening experiences [9, 13, 17, 18, 23–26].
Other determinants are related to cultural beliefs and
health-seeking behaviour found among some ethnic
groups [14, 19, 27–29]. Additionally, migration-related
issues have been highlighted as significant predictors as-
sociated with disparities in the screening participation.
For example, younger age at migration, longer length of
stay in the host country, and a higher level of accultur-
ation, are determinants for a higher likelihood of
screening participation among some immigrant groups
[10, 26, 30–33]. Barriers to screening participation in-
clude limited understanding of screening and low level
of education in the country of origin before migrating
to the host country. Inability to navigate within the
healthcare system and difficulties in obtaining health
information are also barriers [24, 31, 33, 34].
Global mobility as a result of various factors, such as
employment, war crises, education, and family reunion,
raised international migrant numbers to 244 million in
2015. Approximately half (52.4%) of these migrants are
women; [35] the migrant European population has also
grown, with about 76 million migrants [36]. People from
different cultures might have different expectations
based on their health values and beliefs dependent on cul-
tural norms [37]. These might influence their use of
healthcare services, such as cervical screening participa-
tion. More recently, the health status of some immigrant
groups referred to as “vulnerable populations” as com-
pared with that of non-immigrants has drawn attention in
the European public health sector [20, 38]. As such, great
concern exists that immigrants referred to as “hard to
reach” might lack access to healthcare services, such as
screening, compared with the native population [26, 33].
Hence, the World Health Organisation and the European
Commission have set equity in healthcare as a top pri-
ority goal in its member states, to address inequity in
healthcare and to improve healthcare service practices
and delivery [20, 38–40].
Finland has witnessed a substantial growth in its im-
migrant population, including women, in recent years.
According to Statistics Finland, the immigrant popula-
tion increased by 21% in 2016, compared to a year
earlier [41]. Finland has offered organised mass cervical
screening programme since the 1960s, using a five-year
interval among women aged 25–65 [42, 43]. Personal
screening invitation letters are sent to all eligible women,
including immigrants, identified from the Finnish na-
tional population register [43]. In addition, women in
this age group can participate in other (opportunistic)
screening tests offered, or referred to, by their physicians
or other healthcare providers [44]. Hence, in Finland,
the effectiveness of cervical screening is well established
[3, 7, 8, 45]. For instance, cervical screening coverage
among those invited to mass screening is approximately
70% [43], and screening coverage among the general
Finnish population is nearly 90% [44]. The incidence
of cervical cancer is about 4/100,000, and mortality
resulting from cervical cancer is around 1/100,000
women [43].
A previous study in Finland revealed relatively low
screening participation rates as well as differences in,
and significant barriers to cervical screening among
some immigrant groups [9]. However, knowledge is lim-
ited about potential disparities in the screening partici-
pation among different population groups compared
with the general Finnish population.
Idehen et al. International Journal for Equity in Health  (2018) 17:56 Page 2 of 9
In this study, we aimed to examine disparities in self-
reported cervical screening (Pap test) participation
among women of Russian, Somali, and Kurdish, origin
in Finland, compared with the general Finnish popula-
tion (hereafter, Finns). We controlled for differences in
several socio-demographic and health-related variables
as potential confounders. With the increasing population
of various immigrant groups, it is essential to explore
disparities in cervical screening participation and identify-
ing groups at risk of the disease. This study will potentially
contribute to the existing knowledge of cervical screening
participation among various immigrant groups. Addition-
ally, we hope to aid policy making and to develop effective
screening programmes tailored to immigrants and appro-
priate healthcare resource allocation, both at national and
international levels.
Methods
Study population
We employed data from the Finnish population-based
Migrant Health and Well-being Study (Maamu) 2010–2012
[46] and the National Health 2011 Survey [47] conducted
by the Finnish National Institute for Health and Welfare
(THL). The Maamu study sample consists of 3000 immi-
grants: 1000 from Russia or the former Soviet Union, 1000
from Somalia, and 1000 from Iraq or Iran (Kurdish back-
ground) [46]. These immigrant groups represent various
geographical regions and reasons for migration. Among
foreign language speakers in Finland, Russians are the lar-
gest group and Somalis the fourth largest; Kurdish Sorani
speakers comprise the sixth largest group. Recently, Kurds
from Iraq and Iran have been among the major groups in
the quota of refugees accepted into Finland [48]. Our
Somali group comprises mainly refugees and those
women who came to Finland for reuniting with their
families.
A random sample was drawn from the Finnish National
Population Registry and stratified by municipality and par-
ticipants’ country of origin [46]. The inclusion criteria
were as follows: country of birth (Russia/Soviet Union,
Somalia, Iraq or Iran) and mother tongue, as recorded in
the population register. We included Russians (speaking
Russian or Finnish) and Kurds (speaking Kurdish Sorani),
the latter born in Iraq or Iran. Other inclusion criteria
were age 18–64, living in one of the six Finnish cities with
high proportions of immigrants (Helsinki, Espoo, Vantaa,
Tampere, Turku, and Vaasa), and at least one year of stay
in Finland.
Among the 3000 persons (1000 from each immigrant
group) invited to the survey, the minimum participation
rates for any one part of the study protocol were as fol-
lows: Russians 70% (n = 702), Somalis 51% (n = 512), and
Kurds, 63% (n = 632). The study protocol included a
face-to-face interview as well as a health examination
and a health interview, with an option for a short inter-
view for those unable or unwilling to participate in the
longer health examination or interview. We analysed
537 responses on self-reported cervical screening partici-
pation in the previous five years; we obtained these from
immigrants (257 Russians, 113 Somalis, 167 Kurds) aged
29–60, the recommended age range for the Finnish mass
screening programme [43]. The Finnish reference group
comprised participants from the National Population-
based Health 2011 Survey, who lived in the same six
cities as the participants in the Maamu survey. Approxi-
mately, 71% of them participated in at least one part of
the study (n = 1582) [47]; from this reference group, we
had 436 respondents.
Data collection methods
The Maamu study comprises data from structured
face-to-face interviews conducted by trained bilingual
interviewers who used the native languages of the
participants. The interviews consisted of questions on
socio-economic- and health-related issues, including
cervical screening participation. The Health 2011 sur-
vey data were collected using face-to-face interviews
and self-administered questionnaires.
Measures and variables
Based on the Finnish recommendation for the organised
screening programme, the dependent variable in the
study was self-reported cervical screening (Pap test)
participation in the previous five years. As part of the
health interview, participants were asked about any Pap
test taken, including tests in the organised screening
programme and in non-organised settings, such as pri-
vate clinics (opportunistic tests); the answers were re-
corded as ‘yes’ or ‘no.’
Based on earlier studies indicating determinants associ-
ated with screening participation [10, 13, 14, 18, 23, 26, 29],
our analyses considered differences in several potential con-
founders. We selected several potential confounders in the
socio-demographic category: age, level of education, marital
status, number of household members, employment status,
residential area, and income sufficiency. Health-related con-
founders included self-perceived health status and leisure-
time physical exercise; we asked them whether they had
had a chronic illness, abortion, or miscarriage; participants
also responded to whether they were obese (BMI > 30) and
to whether they had ever smoked or given birth.
Statistical analyses
For statistical analyses, we used the StataSE/13 software
package. All analyses used finite population correction
(FPC), with the effects of non-response corrected with
Inverse Probability Weighting (IPW) [49]. The logistic
regression model used for IPW was based on register
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information on the immigrant groups, age group, gender,
city, and marital status. The weights were calibrated using
the population size of each stratum. Using predictive mar-
gins, we calculated the adjusted prevalence estimates [50].
First, we analysed the main descriptive characteristics of
the study population, i.e., weighted and age-adjusted preva-
lence (%) estimates for categorical variables and mean, plus
standard error (SE) for the continuous variable (age). Fur-
ther, we applied multiple logistic regression models to ex-
plore the statistical significance of the disparities in
screening participation among these immigrant groups
compared with Finns, the reference group (OR = 1.00).
Model 1 was adjusted for only age while model 2 was
additionally adjusted for the main effects of selected
socio-demographic and health-related confounders.
Then we tested country of origin-confounder interac-
tions on screening participation, with p < 0.15 as a
threshold. We included those country of origin-
confounder interactions in Model 3, which was the final
model based on the analyses.
Results
Descriptive results
Age-adjusted screening participation rates were as fol-
lows: Russians 79% (95% CI 72.9–84.4), Somalis 41%
(95% CI 31.4–50.1), and Kurds 64% (95% CI 57.2–70.8),
compared with 94% (95% CI 91.4–95.9) among Finns.
Table 1 displays the descriptive characteristics of the
study participants.
Screening participation dependent on country of
origin-confounding variable interactions
Table 2 shows age-adjusted prevalence estimates of the
screening participation based on the most essential con-
founding variables, which had significant interactions
with the country of origin of these immigrant groups.
Married Finns and Somalis participated in screening
more often while Russians and Kurds tended to be the
opposite. Employed Russians and Kurds participated
more actively; employed Finns and Somalis, however,
tended to participate less actively. Russians and Somalis
having one to three household members participated
more, but the opposite was true for Kurds and Finns.
Those living outside of the metropolitan areas of Finland
had higher screening participation among all the groups,
except for the Somalis (Table 2).
Table 3 displays the Odd Ratios [ORs] and 95% Confi-
dence Intervals [CIs] of three logistic regression models
for screening participation among the immigrant groups
compared with the reference group (Finns’ OR = 1.00).
When adjusted for only age, the likelihood of screening
participation among all the immigrant groups was
Table 1 Characteristics of participants by country of origin: weighted and age-adjusted proportions (%)a,b
Characteristics Finnish (n = 436) Russian (n = 257) Somali (n = 113) Kurdish (n = 167)
Age: Years Mean (SE) 44.9 (0.46) 44.8 (0.61) 40.8 (0.81) 40.3 (0.56)
Variable Description Total n of
respondents
n % n % n % n %
Pap test taken in the past
five years
Yes 973 405 93.6 198 78.6 39 40.8 106 64.0
Education High school in any country 971 313 74.8 218 87.6 14 15.6 68 43.9
Marital status Married or cohabiting 970 305 73.9 170 67.0 84 78.8 129 75.4
Household members Above three members 973 117 36.0 55 26.6 83 77.0 92 55.4
Employment status Employed 970 359 79.8 143 51.7 16 15.1 55 32.9
Residential area Outside metropolitan
areas
973 118 24.9 89 16.4 31 9.4 67 43.2
Sufficient income Yes 959 288 69.8 121 48.0 54 42.1 55 34.1
Self-perceived health status Good 973 357 86.1 137 61.9 85 74.1 87 56.2
Ever given birth Yes 928 293 60.9 223 79.9 99 92.8 157 92.4
Ever smoked Yes 972 330 78.6 146 59.7 3 4.0 17 10.1
Obese Body Mass Index (BMI)
≥30 kg/m2
962 91 16.6 54 17.5 49 42.2 47 27.6
Leisure-time physical exercise Active 938 103 28.9 61 28.7 15 19.5 29 19.6
Any chronic illness Yes 972 137 25.1 110 39.0 28 26.9 69 39.8
Any abortion Yes 920 74 15.1 157 58.9 3 1.0 45 26.9
Any miscarriage Yes 924 78 18.2 59 19.8 43 38.8 55 31.6
aFor age, mean and Standard Error (SE)
bAmong women who responded to the question of Pap test participation (n = 973)
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significantly lower. Compared with the reference group,
Somalis had the lowest odds (Model 1). After adjusting
for age and socio-demographic and health-related con-
founders, these disparities remained significant com-
pared with the reference group; all our immigrant
groups demonstrated a significantly lower likelihood of
screening participation (Model 2).
Model 3 provided the results adjusted for the direct ef-
fects of multiple confounders and included country-
confounder interactions. Those confounders which had
major effects were age, socio-demographic (education
and income) and health-related variables. Health-related
confounders included self-perceived health status and
leisure-time physical exercise; we asked them whether
they had had a chronic illness, abortion, or miscarriage;
participants also responded to whether they were obese
(BMI > 30) and to whether they had ever smoked or
given birth. Country of origin and the following confound-
ing variables exhibited significant interaction: marital sta-
tus, employment status, number of household members,
residential area, and whether they had ever smoked.
When we adjusted the final model simultaneously for
these confounders and interactions, compared with the
reference group, we still detected lower OR point esti-
mates of screening participation among all these immi-
grant groups. However, none of the ORs remained
statistically significant, as indicated by the 95% CIs
which include 1 (Table 3).
Discussion
The rationale behind cervical screening using the
Papanicolaou (Pap) test is early detection of “pre-cancerous
lesions” and effective treatment of abnormalities [3–5].
However, full compliance with screening recommenda-
tions is essential to achieve this goal. This population-
based study examined disparities in cervical screening
(Pap test) participation among women of Russian, Somali,
and Kurdish, origin residing in Finland and compared it
with the general Finnish population (Finns), our reference
group. In our analyses, we accounted for country of ori-
gin differences in multiple determinants of cervical
screening were considered as potential confounders.
We also accounted for multiple country of origin-
confounder interactions. The lower odds for screening
participation compared with the Finns indicated signifi-
cant disparities among the immigrant groups studied.
However, such disparities were attenuated when ac-
counting for socio-demographic and health-related
confounders specific to each immigrant group. Thus,
we demonstrated that multiple screening determinants
specific to each country of origin might underlie the
disparities initially observed.
Although Finland offers universal cost-free cervical
screening to all eligible women, including legal immi-
grants, our findings demonstrate disparities among these
immigrants and lower screening participation in com-
parison with the Finns. Our results are consistent with
previous international studies showing disparities in
screening participation among various immigrant groups
in countries offering universal screening programmes
[10–13, 16–18, 23]. Although such disparities have been
widely reported world-wide, to the best of our know-
ledge, similar disparities in Finland have not been pub-
lished earlier.
The main goal of universal healthcare is that “all people
can obtain the health services they need without suffering
Table 2 Age adjusted prevalence of Pap test participation by confounding variables with country of origin interactions
Variables Finnish Russian Somali Kurdish
% % % %
Marital status
Married or cohabiting 96.5 73.7 46.4 63.7
Othersa 87.5 78.8 38.8 66.5
Employment status
Employed 91.2 82.5 38.7 73.8
Not employed 94.7 68.9 49.2 55.2
Household members
One-three members 92.5 76.7 46.6 58.8
Above three members 94.9 73.4 38.0 76.3
Residential areas
Metropolitan areasb 92.4 73.5 53.9 59.9
Other cities/outside of metropolitan areasc 95.1 81.3 14.5 78.5
aIncluding the singles, separated or divorced, and widow
bMetropolitan areas (Helsinki, Espoo, and Vantaa)
cOther cities (Tampere, Turku and Vaasa)
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financial hardship” [51]. This comprises the right of access
to healthcare services, such as cervical screening. How-
ever, disparities in cervical screening practices could lead
to underutilisation of the screening service and thus
increase the incidence of, and mortality from, the
disease [52]. Earlier studies have highlighted the
higher risk of the disease among non-screened partici-
pants or those who seldom participate in the screening,
compared to regularly screened women [4, 16, 21]. This
feature exists especially among some immigrant groups,
Table 3 Logistic regression models for Pap test participation: Odds Ratios (OR) and 95% Confidence Intervals (CI)
Variables Main effects Finnish Russian Somali Kurdish P
OR OR (95% CI) OR (95% CI) OR (95% CI)
Model1 OR (95% CI) 1.00 0.25 (0.15–0.40) 0.05 (0.03–0.08) 0.12 (0.07–0.19)
Model2 Description OR (95% CI) 1.00 0.32 (0.18–0.58) 0.10 (0.04–0.23) 0.17 (0.09–0.35)
Education High school in any country 1.65 (1.09–2.50)
Marital status Married or cohabiting 1.27 (0.80–2.00)
Household members Above 3 members 1.35 (0.83–2.19)
Employment status Employed 1.68 (1.11–2.55)
Residential areas Outside metropolitan 1.72 (1.14–2.58)
Sufficient income Yes 1.36 (0.90–2.07)
Self-perceived health status Good 1.32 (0.80–2.18)
Ever given birth Yes 1.13 (0.62–2.06)
Ever smoked Yes 0.92 (0.55–1.53)
Obese BMI > 30Kg/M2 0.83 (0.54–1.26)
Leisure-time physical exercise Active 1.53 (0.93–2.51)
Any chronic illness Yes 1.66 (1.03–2.66)
Any abortion Yes 1.05 (0.66–1.66)
Any miscarriage Yes 1.19 (0.76–1.86)
Model3 1.00 0.74 (0.16–3.39) 0.34 (0.05–2.49) 0.23 (0.05–1.10) 0.1642
Interaction terms
Marital status Married or cohabiting* 4.58 (1.92–10.9) 1.00 0.16 (0.05–0.51) 0.32 (0.06–1.65) 0.18 (0.05–0.63) 0.0103
Employment status Employed* 0.46 (0.15–1.44) 1.00 4.91 (1.30–18.6) 1.21 (0.20–7.48) 6.07 (1.50–24.6) 0.0225
Household members Above 3 members* 1.47 (0.38–5.64) 1.00 0.56 (0.12–2.63) 0.48 (0.08–2.93) 1.66 (0.37–7.53) 0.1841
Residential areas Outside metropolitan* 1.53 (0.57–4.15) 1.00 1.05 (0.30–3.68) 0.08 (0.01–0.57) 1.77 (0.52–6.01) 0.0130
Ever smoked Yes 3.15 (1.39–7.16) 1.00 0.25 (0.08–0.75) N/A 0.13 (0.03–0.58) 0.0091
Education High school 1.79 (1.16–2.77)
Sufficient income Yes 1.50 (0.97–2.30)
Self-perceived health status Good 1.33 (0–79-2.25)
Ever given birth Yes 1.06 (0.55–2.04)
Obese BMI > 30Kg /M2 0.81 (0.52–1.25)
Leisure-time physical exercise Active 1.50 (0.88–2.57)
Any chronic illness Yes 1.64 (0.98–2.73)
Any abortion Yes 0.98 (0.60–1.61)
Any miscarriage Yes 1.29 (0.81–2.06)
1Adjusted for age
2Adjusted for age, education, marital status, employment status, family size, residential area, sufficient income, self-rated health status, ever given birth, obesity
(BMI), physical exercise, any chronic illness, any abortions, any miscarriage, and ever smoked
3Adjusted for age, education, marital status, employment status, household members, residential area, sufficient income, self-rated health status, ever given birth,
obesity (BMI) physical exercise, any chronic illness, any abortions, any miscarriage, ever smoked. Including study group Interactions with: Marital status, employment
status, residential areas, household members and ever smoked
N/A not available due to no smokers in this group
*Interaction p-values (Interaction –test results)
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compared with the native population [4, 11, 12, 16, 23].
With immigrant population increasing, disparities that
persist will increase national healthcare expenditure [52].
When observing such disparities, it is relevant to ask
why some immigrant women have lower adherence to
recommendations related to women’s health. Accord-
ing to previous studies, non-adherence to screening
recommendations among some immigrant groups has
associations with lack of knowledge about screening,
lack of disease symptoms, and religious faith. Not hav-
ing a female healthcare professional to perform the
screening test may also function as a barrier to screen-
ing participation [13, 14, 25, 27–29, 53]. Based on an
earlier study [54], perceptions about, or differences in
healthcare service practices or delivery in the country
of origin of the immigrant and his/her host country
might also contribute to the problem. Participants in
this particular study expected their healthcare pro-
viders to take an active role in preventive healthcare
advice or recommendations as it was practised in their
country of origin. Two studies have demonstrated the
role of healthcare providers and personal physicians;
providing referrals for screening increases the likeli-
hood of screening participation [4, 55]. Migration-
related issues, namely, longer period of stay in the
host country, younger age at migration, and higher
level of acculturation, are determinants for screening par-
ticipation among some immigrant groups [14, 26, 31–33].
However, in this study we did not adjust for these deter-
minants, because our main focus was in comparison with
the general Finnish population, where such variables are
irrelevant.
In our study, overall, among these immigrant groups,
the highest screening participation rate was observed
among Russians followed by the Kurds while the Somalis
had the lowest participation rate; these results are con-
sistent with those of an earlier study [9]. These popula-
tion groups have migrated from different continents and
countries; thus, their cultural beliefs, norms, health be-
liefs, religion, ethnicity, and health-seeking behaviours,
might vary [13, 14, 53, 54, 56].
The relatively active screening participation among
Russian women compared with other immigrant women
might be partly due to their higher level of language pro-
ficiency, with about 90% understanding Finnish or Swed-
ish, the official languages of Finland, as demonstrated in
an earlier study [9]. Understanding the official language
of the host country increases the likelihood of screening
participation [9, 13, 23, 25, 33, 55]. Adequate language
skills enable the individual to navigate within the health-
care system for obtaining health promotion information,
such as the importance and aims of the screening.
Language skills also facilitate effective communication
with healthcare officials [9, 32, 33, 55].
We adjusted our analyses for differences in multiple
confounders, which may at least partly explain some of
the disparities initially observed. For example, the associ-
ation between higher screening participation and being
married or cohabiting, although found only among Finns
and Somalis, could explain the essential role of the hus-
band or partner in screening participation, consistent
with a previous study [53]. Further, the low screening
participation found among Somali or Muslim women
might be related to unfamiliarity with screening due to
the unavailability of the screening programme, lack of
understanding of healthcare practices, or lack of
screening affordability, in their country of origin [57].
Additionally, some Somali women have poor language
proficiency, low level of education, or both; thus, they
are unable to obtain health information, as shown in
previous studies [9, 24, 31, 33, 34]. The experience(s)
of embarrassment associated with female genital muti-
lation (FGM) or anxiety associated with screening and
unpleasant screening experience(s), or both, might in-
fluence them [24, 33]. Further, the lower screening
participation rate among Somalis living outside the
metropolitan areas of Finland might be related to diffi-
culties in transportation. Similar features were pre-
sented in mammogram screening [19].
To increase cervical screening participation among
these immigrant groups, promoting screening awareness,
disseminating information and offering education in the
immigrants’ native language, as well as providing inter-
preters and female health professionals, are vital. Orga-
nising transportation when possible might also be
helpful [24, 28, 29, 33, 34, 56, 58].
Strengths and limitations of the study
This study has a population-based design and a reason-
able response rate among Russian, Kurdish, and Finnish,
participants. Bilingual interviewers who spoke and
understood the native language of the participants them-
selves interviewed the participants; most were female.
This feature enhances participant willingness and en-
ables addressing gender-related issues. It also offered an
opportunity to clarify research aims or questions raised
during the interview [46].
The study also has some limitations. Responses to cer-
vical screening participation based on retrospective self-
reporting might involve some recall bias [59]. Response
rates differed across immigrant groups. One explanation
for this might be the differences in cultural backgrounds
and beliefs; their reasons for migration are different. Ref-
ugees may be more concerned about data secrecy and
may harbour more mistrust towards authorities. Further-
more, the particularly low survey response rate among
Somalis might bias the results and limit the statistical
power of the analyses. However, this limitation was
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statistically accounted for. Nonetheless, to the best of
our knowledge, ours is the first study to analyse and re-
port disparities in cervical screening participation among
immigrant groups compared with the general Finnish
population.
Conclusions
Although Finland offers universal cervical screening to
all eligible women, our results indicate disparities in
screening participation among these immigrants and a
lower likelihood of screening participation compared with
the general Finnish population. To improve equity in cer-
vical cancer screening participation, appropriate culturally
tailored intervention programmes for each immigrant
group might be beneficial. Further research is needed to
enhance understanding of cultural and health beliefs, as
well as of norms which may be specific to each immigrant
group; we especially need qualitative studies.
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